Defensin alpha 8, pseudogene (DEFA8P)

Defensin alpha 8, pseudogene (DEFA8P) belongs to the α-defensin multigene family, which encodes antimicrobial peptides involved in innate immune defense[1][3]. However, DEFA8P is a **pseudogene**—meaning it is a non-functional remnant of a formerly active gene. Unlike functional α-defensin genes such as DEFA1, DEFA3, DEFA4, DEFA5, and DEFA6, which encode peptides that contribute to host defense, DEFA8P does not produce a functional protein and is not expressed or involved in biological activity in humans[1]. Such pseudogenes arise through gene duplication and subsequent inactivation and may serve as evolutionary markers but do not have direct functional or therapeutic relevance[1][3]. **Key points and supporting details:** - **Not a therapeutic target:** As a pseudogene, DEFA8P does not encode a functional receptor, enzyme, or other druggable protein, nor is it noted as involved in any described signaling pathway or disease process in humans[1][3]. - **Aliases:** The entries DEFAP1, DEFAP1, and DEFA8P are alternative names; however, often, DEFAP1 is a generic pseudogene nomenclature and not always specific[1]. - **Pseudogenes in the family:** The α-defensin locus in humans contains both functional defensin genes and multiple pseudogenes (including DEFAP and DEFTP)[1]. - **Biological role of functional α-defensins:** While the functional α-defensins are small, cationic peptides that disrupt microbial membranes and contribute to innate immunity, pseudogenes like DEFA8P do not participate in these processes[2][3]. **Conclusion:** DEFA8P is a **non-functional pseudogene** within the defensin family, unrelated to therapeutic intervention or functional molecular mechanisms; thus, it is not considered a drug target or of direct biomedical significance[1][3].

Other names

DEFAP1DEFA8P